Genentech
Data Science with Real World Data in Pharma
Genentech

Data Science with Real World Data in Pharma

Adriana Reyes
Otto Fajardo

ä½ę•™åøˆļ¼šAdriana Reyes

2,345 äŗŗå·²ę³Øå†Œ

åŒ…å«åœØ Coursera Plus äø­

ę·±å…„äŗ†č§£äø€äøŖäø»é¢˜å¹¶å­¦ä¹ åŸŗē”€ēŸ„čÆ†ć€‚
äø­ēŗ§ 等级

ęŽØčä½“éŖŒ

9 å°ę—¶ 完成
ēµę“»ēš„č®”åˆ’
č‡Ŗč”Œå®‰ęŽ’å­¦ä¹ čæ›åŗ¦
ę·±å…„äŗ†č§£äø€äøŖäø»é¢˜å¹¶å­¦ä¹ åŸŗē”€ēŸ„čÆ†ć€‚
äø­ēŗ§ 等级

ęŽØčä½“éŖŒ

9 å°ę—¶ 完成
ēµę“»ēš„č®”åˆ’
č‡Ŗč”Œå®‰ęŽ’å­¦ä¹ čæ›åŗ¦

ę‚Øå°†å­¦åˆ°ä»€ä¹ˆ

  • Explain how real world data/evidence fits into the drug development process

  • Describe the three major types of bias that can be encountered in observational studies

  • Apply basic survival analysis techniques such as Kaplan-Meier plots and Cox Models to synthetic data.

č¦äŗ†č§£ēš„čÆ¦ē»†äæ”ęÆ

åÆåˆ†äŗ«ēš„čÆä¹¦

ę·»åŠ åˆ°ę‚Øēš„é¢†č‹±ę”£ę”ˆ

作业

5 锹作业

ęŽˆčÆ¾čÆ­čØ€ļ¼šč‹±čÆ­ļ¼ˆEnglish)

äŗ†č§£é”¶ēŗ§å…¬åøēš„å‘˜å·„å¦‚ä½•ęŽŒę”ēƒ­é—ØęŠ€čƒ½

Petrobras, TATA, Danone, Capgemini, P&G 和 L'Oreal ēš„å¾½ę ‡

čÆ„čÆ¾ēØ‹å…±ęœ‰5äøŖęØ”å—

In this module we briefly introduce the phases in drug development and the evidence generation process to bring treatments to patients. We then exemplify how real-world data/evidence fits into the drug development.

ę¶µē›–ēš„å†…å®¹

5个视频4ēÆ‡é˜…čÆ»ęę–™1个作业1äøŖč®Øč®ŗčÆé¢˜

In this module, we explore the limitations of real-world data. We discuss several sources of real-world data and explain their strengths and weaknesses. We then create clearer definitions of the types of bias that can be encountered when exploring real-world data.

ę¶µē›–ēš„å†…å®¹

3个视频1个作业2äøŖč®Øč®ŗčÆé¢˜

In this module we explore study designs for observational data and methods to control for bias (systematic errors). We also mention concrete examples used in pharmaceutical research.

ę¶µē›–ēš„å†…å®¹

3个视频4ēÆ‡é˜…čÆ»ęę–™1个作业1äøŖč®Øč®ŗčÆé¢˜

In this module we will design and conduct our own study using synthetic data to explore the concepts learned in modules 1-3.

ę¶µē›–ēš„å†…å®¹

5个视频1个作业1äøŖč®Øč®ŗčÆé¢˜3äøŖéžčÆ„åˆ†å®žéŖŒå®¤

In this module we consider the point of view of two critical stakeholders: regulators and payers. We see their position about real world data/evidence and its acceptance. We also explore specific use cases of how real world evidence has been used in practice.

ę¶µē›–ēš„å†…å®¹

3个视频4ēÆ‡é˜…čÆ»ęę–™1个作业2äøŖč®Øč®ŗčÆé¢˜

ä½ę•™åøˆ

Adriana Reyes
Genentech
1 门课程2,345 åå­¦ē”Ÿ
Otto Fajardo
Genentech
1 门课程2,345 åå­¦ē”Ÿ

ęä¾›ę–¹

Genentech

从 Data Analysis ęµč§ˆę›“å¤šå†…å®¹

äŗŗä»¬äøŗä»€ä¹ˆé€‰ę‹© Coursera ę„åø®åŠ©č‡Ŗå·±å®žēŽ°čŒäøšå‘å±•

Felipe M.
自 2018å¼€å§‹å­¦ä¹ ēš„å­¦ē”Ÿ
''čƒ½å¤ŸęŒ‰ē…§č‡Ŗå·±ēš„é€Ÿåŗ¦å’ŒčŠ‚å„å­¦ä¹ čÆ¾ēØ‹ę˜Æäø€ę¬”å¾ˆę£’ēš„ē»åŽ†ć€‚åŖč¦ē¬¦åˆč‡Ŗå·±ēš„ę—¶é—“č”Øå’Œåæƒęƒ…ļ¼Œęˆ‘å°±åÆä»„å­¦ä¹ ć€‚'
Jennifer J.
自 2020å¼€å§‹å­¦ä¹ ēš„å­¦ē”Ÿ
''ęˆ‘ē›“ęŽ„å°†ä»ŽčÆ¾ēØ‹äø­å­¦åˆ°ēš„ę¦‚åæµå’ŒęŠ€čƒ½åŗ”ē”Øåˆ°äø€äøŖä»¤äŗŗå…“å„‹ēš„ę–°å·„ä½œé”¹ē›®äø­ć€‚'
Larry W.
自 2021å¼€å§‹å­¦ä¹ ēš„å­¦ē”Ÿ
''å¦‚ęžœęˆ‘ēš„å¤§å­¦äøęä¾›ęˆ‘éœ€č¦ēš„äø»é¢˜čÆ¾ēØ‹ļ¼ŒCoursera ä¾æę˜Æęœ€å„½ēš„åŽ»å¤„ä¹‹äø€ć€‚'
Chaitanya A.
''å­¦ä¹ äøä»…ä»…ę˜ÆåœØå·„ä½œäø­åšēš„ę›“å„½ļ¼šå®ƒčæœäøę­¢äŗŽę­¤ć€‚Coursera č®©ęˆ‘ę— é™åˆ¶åœ°å­¦ä¹ ć€‚'
Coursera Plus

é€ščæ‡ Coursera Plus å¼€åÆę–°ē”Ÿę¶Æ

ę— é™åˆ¶č®æé—® 10,000+ äø–ē•Œäø€ęµēš„čÆ¾ēØ‹ć€å®žč·µé”¹ē›®å’Œå°±äøšå°±ē»ŖčÆä¹¦čÆ¾ēØ‹ - ę‰€ęœ‰čæ™äŗ›éƒ½åŒ…å«åœØę‚Øēš„č®¢é˜…äø­

é€ščæ‡åœØēŗæå­¦ä½ęŽØåŠØę‚Øēš„čŒäøšē”Ÿę¶Æ

čŽ·å–äø–ē•Œäø€ęµå¤§å­¦ēš„å­¦ä½ - 100% 在线

åŠ å…„č¶…čæ‡ 3400 家选择 Coursera for Business ēš„å…Øēƒå…¬åø

ęå‡å‘˜å·„ēš„ęŠ€čƒ½ļ¼Œä½æå…¶åœØę•°å­—ē»ęµŽäø­č„±é¢–č€Œå‡ŗ

åøøč§é—®é¢˜